Top Markets
Coin of the day
Mercury Biopharmaceutical Corporation Mercury Biopharmaceutical Corporation

Mercury Biopharmaceutical Corporation

6932
Rang in Aktien #23452
Founded in 2019 and headquartered in New Taipei City, Taiwan, Mercury... Founded in 2019 and headquartered in New Taipei City, Taiwan, Mercury Biopharmaceutical Corporation is dedicated to creating innovative pharmaceutical solutions for medical conditions currently lacking adequate treatment options. A cornerstone of their strategy is the proprietary StackDose platform, an advanced drug development system designed to formulate novel medication delivery methods. This platform facilitates precisely timed drug release, targeted absorption at specific locations within the body, and flexible dosage modifications. The primary objective of StackDose is to significantly boost the bioavailability of active pharmaceutical ingredients, leading to a reduction in required drug dosages and fewer adverse effects. Their development pipeline currently addresses a variety of ailments, such as erectile dysfunction, pulmonary hypertension, sleep disturbances, benign prostatic hyperplasia, angina, migraines, hypertension, and pain management.
Aktienkurs
$0.17616661
Zuletzt synchronisiert: 2026-08-21
Marktkapitalisierung
$73.48M
Veränderung (1 Tag)
0.18%
Veränderung (1 Jahr)
-37.76%
Land
TW
Handel Mercury Biopharmaceutical Corporation (6932)

Kategorie

Preis 6932 mit Marktkapitalisierung von B
Mercury Biopharmaceutical Corporation Mercury Biopharmaceutical Corporation
6932
$0.17616661
Marktkapitalisierung von Mercury Biopharmaceutical Corporation(6932)
Marktkapitalisierung: $73.48M
Mit Stand August 2026 hat Mercury Biopharmaceutical Corporation eine Marktkapitalisierung von $73.48M. Das macht Mercury Biopharmaceutical Corporation laut unseren Daten zum 23452nd wertvollsten Unternehmen der Welt nach Marktkapitalisierung. Die Marktkapitalisierung ist der Gesamtmarktwert aller ausstehenden Aktien eines börsennotierten Unternehmens und wird häufig verwendet, um den Unternehmenswert zu bestimmen.
Marktkapitalisierung von Mercury Biopharmaceutical Corporation von 2022 bis 2026
6932 im Vergleich zu den Top 5 der beliebtesten stocks
Preis für 6932 Vermögenswert B Marktkapitalisierung von B Ergebnisse
Mercury Biopharmaceutical Corporation Mercury Biopharmaceutical Corporation
$12,494.73 $73.48M
$5.211T +7,092,465.41%
Mercury Biopharmaceutical Corporation Mercury Biopharmaceutical Corporation
$10,901.24 $73.48M
$4.547T +6,187,927.37%
Mercury Biopharmaceutical Corporation Mercury Biopharmaceutical Corporation
$9,979.92 $73.48M
$4.162T +5,664,943.80%
Mercury Biopharmaceutical Corporation Mercury Biopharmaceutical Corporation
$8,614.04 $73.48M
$3.593T +4,889,613.96%
Mercury Biopharmaceutical Corporation Mercury Biopharmaceutical Corporation
$6,696.12 $73.48M
$2.793T +3,800,917.04%